This award acknowledges achievements in biomedical research that will have a significant impact on human health. Professor Marc Feldmann and Sir Ravinder Maini have both played a crucial role in the discovery of tumor necrosis factor-alpha as a therapeutic target for Rheumatoid Arthritis {1}.

F1000 Medicine would like to congratulate Professor Marc Feldmann and Sir Ravinder Maini on this fantastic achievement and we wish them all the success for the future.

Reference:
{1} http://www.itnews.it/news/2008/0513060402066/professors-marc-feldmann-and-sir-ravinder-maini-named-winners-of-the-2008-dr-paul-janssen-award-for-biomedical-research.html